Quantitative Proton Magnetic Resonance Spectroscopy of Children with Adrenoleukodystrophy before and after Hematopoietic Stem Cell Transplantation

Neuropediatrics

Volumn 34, Issue 5, 2003, Pages 237-246

  Wilken, B ^c   Dechent, P ^a   Brockmann, K ^c   Finsterbusch, J ^a   Baumann, M ^c   Ebell, W ^b   Korenke, G C ^c   Pouwels, P J W ^a   Hanefeld, F A ^c   Frahm, Jens ^a  

^a Biomedizinische NMR Forschungs GmbH   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c NONE

Author keywords

Childhood adrenoleukodystrophy; Demyelination; Magnetic resonance spectroscopy; Neurodegeneration

Indexed keywords

CHOLINE DERIVATIVE; N ACETYLASPARTIC ACID;

ADOLESCENT; ADRENOLEUKODYSTROPHY; ARTICLE; CHILD; CLINICAL ARTICLE; DEMYELINATION; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

ADRENOLEUKODYSTROPHY; ASPARTIC ACID; BRAIN; CHILD; FOLLOW-UP STUDIES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; NERVE REGENERATION; POSTOPERATIVE CARE; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROTONS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 10744220226     PISSN: 0174304X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-43254     Document Type: Article

References (28)

1. Aubourg P, Blanche S, Jambaque I, Rocchiccioli F, Kalifa G, Naud-Saudreau C et al. Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med 1990; 322: 1860-1866
2. Baumann M, Korenke GC, Weddige-Diedrichs A, Wilichowski E, Hunneman DH, Wilken B et al. Hematopoietic stem cell transplantation in 12 patients with cerebral X-linked adrenoleukodystrophy. Eur J Pediatr 2003; 162: 6-14
3. Bezman L, Moser HW. Incidence of X-linked adrenoleukodystrophy and the relative frequency of its phenotypes. Am J Med Genet 1998; 76: 415-419
4. 1H NMR spectroscopic studies of brain, Neurosci Biobehav Rev 1989; 13: 23-31
5. Bjartmar C, Battistuta J, Terada N, Dupree E, Trapp BD. N-Acetylaspartate is an axon-specific marker of mature white matter in vivo: A biochemical and immunohistochemical study on the rat optic nerve, Ann Neurol 2002; 51: 51-58
6. Brand A, Richter-Landsberg C, Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993; 15: 289-298
7. Dubois-Dalcq M, Feigenbaum V, Aubourg P. The neurobiology of X-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder. Trends Neurosci 1999; 22: 4-12
8. Eichler FS, Barker PB, Cox C, Edwin D, Ulug AM, Moser HW, Raymand GV. Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy. Neurology 2002; 58: 901-907
9. Frahm J, Michaelis T, Merboldt KD, Bruhn H, Gyngell ML, Hänicke. Improvements in localized proton NMR spectroscopy of human brain. Water suppression, short echo times, and 1 mL resolution. J Magn Reson 1990; 90: 464-473
10. Frahm J, Hanefeld F. Localized proton magnetic resonance spectroscopy of brain disorders in childhood. In: Bachelard HS (Ed). Advances in Neurochemistry. Vol. 8. New York: Plenum, 1997: 329-402
11. Korenke GC, Christen HJ, Hunnemann DH, Hanefeld F. Failure of beta interferon therapy in X-linked adrenoleukodystrophy. Eur J Pediatr 1996; 155: 833
12. Korenke GC, Pouwels PJW, Frahm J, Hunneman DH, Stoeckler S, Krasemann E et al. Arrested cerebral adrenoleukodystrophy: A clinical and proton magnetic resonance spectroscopy study in three patients. Pediatr Neurol 1996; 15: 103-107
13. Loes DJ, Hite S, Moser H, Stillman AE, Shapiro E, Lockman L et al. Adrenoleukodystrophy: A scoring method for brain MR observations. AJNR 1994; 15: 1761-1766
14. Loes DJ, Stillman AE, Hite S, Shapiro E, Lockman L, Latchaw RE et al. Childhood cerebral form of adrenoleukodystrophy: Short-term effect of bone marrow transplantation on brain MR observations. AJNR 1994; 15: 1767-1771
15. Malta G, Ringdén O, Anvret M, von Dobeln U, Hagenfeldt L, Isberg B et al. Treatment of adrenoleukodystrophy with bone marrow transplantation. Acta Pediatr 1997; 86: 484-492
16. Moser HW, Tutschka PJ, Brown FR, Moser AE, Yeager AM, Singh I et al. Bone marrow transplant in adrenoleukodystrophy. Neurology 1984; 34: 1410-1417
17. Moser HW. Adrenoleukodystrophy: Phenotype, genetics, pathogenesis and therapy. Brain 1997; 120: 1485-1508
18. Moser HW, Bezman L, Lu SE, Raymond GV. Therapy of X-linked adrenoleukodystrophy: Prognosis based upon age and MRI abnormality and plans for placebo-controlled trials. J Inherit Metab Dis 2000; 23: 273-277
19. Moser HW, Loes DJ, Melhem ER, Raymond GV, Bezman L, Cox CS et al. X-Linked adrenoleukodystrophy: Overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients. Neuropediatrics 2000; 31: 227-239
20. Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, Moser H et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 1993; 361: 726-730
21. Pouwels PJW, Kruse B, Korenke GC, Mao X, Hanefeld FA, Frahm J. Quantitative proton magnetic resonance spectroscopy of childhood adrenoleukodystrophy. Neuropediatrics 1998; 29: 1-11
22. Pouwels PJW, Brockmann K, Kruse B, Wilken B, Wick M, Hanefeld F et al. Regional age dependence of human brain metabolites from infancy to adulthood as detected by quantitative localized proton MRS. Pediatr Res 1999; 46: 474-485
23. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-679
24. Shapiro E, Krivit W, Lockman L, Jambaque I, Peters C, Cowan M et al. Long-term effect of bone marrow transplantation for childhood onset cerebral X-linked adrenoleukodystrophy. Lancet 2000; 356: 713-718
25. Smith KD, Kemp S, Braiterman LT, Lu JF, Wei HM, Geraghty M et al. X-linked adrenoleukodystrophy: Genes, mutations, and phenotypes. Neurochem Res 1999; 24: 521-535
26. Suzuki Y, Isogai K, Teramoto T, Tashita H, Shimozawa N, Nishimura M et al. Bone marrow transplantation for the treatment of X-linked adrenoleukodystrophy. J Inherit Metab Dis 2000; 23: 453-458
27. Suzuki Y, Imamura A, Shimozawa N, Kondo N. The clinical course of childhood and adolescent adrenoleukodystrophy before and after Lorenzo's oil. Brain Dev 2001; 23: 30-33
28. Wilken B, Dechent P, Herms J, Maxton C, Markakis E, Hanefeld F et al. Quantitative proton magnetic resonance spectroscopy of focal brain lesions. Pediatr Neurol 2000; 23: 22-31